Has Grigory Goldberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $160,952 in general payments to Grigory Goldberg, MD across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Grigory Goldberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Grigory Goldberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Grigory Goldberg, MD

Orthopaedic Surgery of the Spine · Ocean, NJNPI 1033142112

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $141,421 of the $160,952 with a category attached, or 87.9%. Surgalign Spine Technologies, Inc. accounts for 85.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $42,575 and has fallen 97.0% since, to $1,264 in 2025. Among orthopaedic surgery of the spine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$160,952in general payments, 2019–2025

Across 86 payments — averaging $1871.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Surgalign Spine Technologies, Inc.$137K
Xtant Medical Inc$15K
Depuy Synthes Products, Inc.$5K
Stryker$1K
Globus Medical$1K
Johnson & Johnson$689
plus $1K from 8 others

What the payments were for

Royalty or licence$141,42188%
Consulting fees$14,4159%
Travel & lodging$1,6891%
Food & beverage$3,4272%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Surgalign Spine Technologies, Inc.	24	$136,738
Xtant Medical Inc	4	$15,277
Depuy Synthes Products, Inc.	8	$4,704
Stryker	10	$1,383
Globus Medical	17	$1,008
Johnson & Johnson	10	$689
Alphatec Spine, Inc	3	$336
Centinel Spine, LLC	2	$248
Ossdsign USA Incorporated	3	$222
Boston Scientific	1	$140
Nevro Corp.	1	$114
Zimmer Biomet	1	$47
Si-bone, Inc.	1	$27
Abbott	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FORTILINK-C IBF SYSTEM$130,946
STREAMLINE MIS SPINAL FIXATION SYSTEM$5,580
ES2$955
LATERAL ACCESS SPINAL SYSTEM$489
GENERAL K2M PRODUCT DISCUSSION$489
Expedium VERSE$441
IdentiTi$260
EVEREST$172
CASCADIA INTERBODY SYSTEM$157
ALLOGRAFT$151
AttraX$148
PRODISC L$144
GENERAL PAIN MANAGEMENT$140
XLIF$139
Senza$114
ACP$107
PRODISC C VIVO$104
OssDsign Catalyst$100

How this compares

$160,952 in reported general payments places this provider in the 90th percentile of 84 orthopaedic surgery of the spine providers in New Jersey.

See all orthopaedic surgery of the spine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$42,446

Medicare patients

199

Services billed

598

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	16	$102
Methylprednisolone	19	$101
Meloxicam	27	$81
Baclofen	13	$56

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Ocean

Douglas NowackiOcean$17K
Vincent BuddleOcean$14K
Kristen RadcliffSomers Point$390K
James SanfilippoMoorestown$380K
Justin KubeckToms River$309K
Ramil BhatnagarManasquan$301K
Jason LowensteinMorristown$294K
Steven KirshnerMarlton$226K
Gordon DonaldEatontown$167K
Ki HwangWayne$147K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →